NASDAQ:MESO
Mesoblast Limited
- Stock
locale
Australia
market
STOCKSindustry
Biotechnologywebsite
www.mesoblast.comipo date
Dec 15, 2004
Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is bas...Show More
Earnings
Earnings Release in 2 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus